ScholarIQanswers from OpenAlex
World Diabetes Foundation
InstitutionResearch output, impact & collaborations
World Diabetes Foundation is a institution indexed in ScholarIQ from OpenAlex.
What is known about World Diabetes Foundation?
ScholarIQrecord summary
World Diabetes Foundation is a research organisation in Skævinge, Denmark. OpenAlex records 164 works and 10,978 citations for it. 1 researchers list it as their most recent affiliation.
How many works does World Diabetes Foundation have?
ScholarIQindexed works
World Diabetes Foundation has 164 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does World Diabetes Foundation have?
ScholarIQcitation count
World Diabetes Foundation has 10,978 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at World Diabetes Foundation?
ScholarIQresearcher count
World Diabetes Foundation has 1 researchers in the ScholarIQ index.
What is the average h-index at World Diabetes Foundation?
ScholarIQavg h-index
World Diabetes Foundation has an average h-index of 75 in OpenAlex.
What is the ROR of World Diabetes Foundation?
ScholarIQror
The ROR for World Diabetes Foundation is on the source record.
What is the OpenAlex record for World Diabetes Foundation?
ScholarIQopenalex
The OpenAlex for World Diabetes Foundation is on the source record.
Who are the most-cited researchers behind World Diabetes Foundation?
ScholarIQtop researchers by citations
What are the most-cited papers on World Diabetes Foundation?
ScholarIQmost cited works
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm
Anna Helgadóttir, Guðmar Þorleifsson, Kristinn P. Magnússon, Sólveig Grétarsdóttir, Valgerður Steinthórsdóttir, Andrei Manolescu, Gregory T. Jones, Gabriël J.E. Rinkel, Jan D. Blankensteijn, Antti Ronkainen, Juha E. Jääskeläinen, Yoshiki Kyo, Guy M. Lenk, Natzi Sakalihasan, Konstantinos Kostulas, Anders Gottsäter, Andrea Flex, Hreinn Stefánsson, Torben Hansen, Gitte Andersen, Shantel Weinsheimer, Knut Borch‐Johnsen, Torben Jørgensen, Svati H. Shah, Arshed A. Quyyumi, Christopher B. Granger, Muredach P. Reilly, Harland Austin, Allan I. Levey, Viola Vaccarino, Ebba Pálsdóttir, G. Bragi Walters, Þorbjörg Jónsdóttir, Steinunn Snorradóttir, Dana Magnusdottir, Guðmundur H. Guðmundsson, Robert E. Ferrell, Sigurlaug Sveinbjörnsdóttir, Juha Hernesniemi, Mika Niemelä, Raymond Limet, Karl Andersen, Gunnar Sigurðsson, Rafn Benediktsson, Eric L.G. Verhoeven, Joep A.W. Teijink, Diederick E. Grobbee, Daniel J. Rader, David Collier, Oluf Pedersen, Roberto Pola, Jan Hillert, Bengt Lindblad, Einar Már Valdimarsson, Hulda B. Magnadottir, Cisca Wijmenga, Gerard Tromp, Annette F. Baas, Ynte M. Ruigrok, André M. van Rij, Helena Kuivaniemi, Janet T. Powell, Stefán E. Matthíasson, Jeffrey R. Gulcher, Guðmundur Þorgeirsson, Augustine Kong, Unnur Þorsteinsdóttir, Kāri Stefánsson
Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes
Klaus Klausen, Knut Borch‐Johnsen, Bo Feldt‐Rasmussen, Gorm Boje Jensen, Peter Clausen, Henrik Scharling, Merete Appleyard, Jan Skov Jensen
A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk
Nabila Bouatia‐Naji, Amélie Bonnefond, Christine Cavalcanti-Proença, Thomas Sparsø, Johan Holmkvist, Marion Marchand, Jérôme Delplanque, Stéphane Lobbens, Ghislain Rocheleau, Emmanuelle Durand, Franck De Graeve, Jean-Claude Chèvre, Knut Borch‐Johnsen, Anna‐Liisa Hartikainen, Aimo Ruokonen, Jean Tichet, Michel Marre, Jacques Weill, Barbara Heude, M. Tauber, Katleen Lemaire, Frans Schuit, Paul Elliott, Torben Jørgensen, G. Charpentier, Samy Hadjadj, Stéphane Cauchi, Martine Vaxillaire, Robert Sladek, Sophie Visvikis‐Siest, Beverley Balkau, Claire Lévy‐Marchal, François Pattou, Stephen Eyre, Alexandra I. F. Blakemore, Marjo‐Riitta Järvelin, Andrew J. Walley, Torben Hansen, Christian Dina, Oluf Pedersen, Philippe Froguel
European guidelines on cardiovascular disease prevention in clinical practice<SBT>Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
Guy De Backer, Ettore Ambrosioni, Knut Borch‐Johnsen, Carlos Brotons, Renata Cífková, Jean Dallongeville, Shah Ebrahim, Ole Færgeman, Ian D. Graham, Giuseppe Mancia, V. Manger Cats, Kristina Orth‐Gomér, Joep Perk, Kalevi Pyörälà, José L. Rodicio, Susana Sans, Vedat Sansoy, Udo Sechtem, Sigmund Silber, Troels Thomsen, David Wood
Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia
Johan Rung, Stéphane Cauchi, Anders Albrechtsen, Li Shen, Ghislain Rocheleau, Christine Cavalcanti-Proença, François Bacot, Beverley Balkau, Alexandre Bélisle, Knut Borch‐Johnsen, G. Charpentier, Christian Dina, Emmanuelle Durand, Paul Elliott, Samy Hadjadj, Marjo‐Riitta Järvelin, Jaana Laitinen, Torsten Lauritzen, Michel Marre, Alexander M. Mazur, Stephen Eyre, Alexandre Montpetit, Charlotta Pisinger, Barry I. Posner, Pernille Poulsen, Anneli Pouta, Marc Prentki, Rasmus Ribel‐Madsen, Aimo Ruokonen, Anelli Sandbæk, David Serre, Jean Tichet, Martine Vaxillaire, Jørgen F. P. Wojtaszewski, Allan Vaag, Torben Hansen, Constantin Polychronakos, Oluf Pedersen, Philippe Froguel, Robert Sladek
How much of the research on World Diabetes Foundation is open access?
ScholarIQopen access share
38%OPEN ACCESS